Process View
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of polysaccharides.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of polysaccharide biosynthetic process"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| INSR | insulin receptor | 1.000 | ||
| GRB10 | growth factor receptor-bound protein 10 | 0.987 | Rat | |
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.944 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.937 | ||
| NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.935 | Human | |
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.859 | ||
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.840 | Human | |
| DYRK1B | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B | 0.760 | Human | |
| NUMB | numb homolog (Drosophila) | 0.740 | ||
| PRKCZ | protein kinase C, zeta | 0.698 | Human | |
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.679 | ||
| APBB1 | amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) | 0.676 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.671 | ||
| EGFR | epidermal growth factor receptor | 0.642 | ||
| BCL3 | B-cell CLL/lymphoma 3 | 0.498 | ||
| NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.426 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.421 | ||
| MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.391 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.351 | ||
| IRS2 | insulin receptor substrate 2 | 0.263 | ||
| HIP1 | huntingtin interacting protein 1 | 0.260 | ||
| NRP1 | neuropilin 1 | 0.259 | ||
| DYRK1A | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A | 0.242 | Human | |
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.215 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.205 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.198 | ||
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.180 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.176 | ||
| NOXA1 | NADPH oxidase activator 1 | 0.173 | ||
| AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.171 | ||
| LZTS2 | leucine zipper, putative tumor suppressor 2 | 0.167 | ||
| IRS1 | insulin receptor substrate 1 | 0.167 | ||
| PPP1R2 | protein phosphatase 1, regulatory (inhibitor) subunit 2 | 0.137 | ||
| NFKBIB | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta | 0.131 | ||
| IGF1R | insulin-like growth factor 1 receptor | 0.121 | Human | |
| ENG | endoglin | 0.109 | ||
| HTT | huntingtin | 0.109 | ||
| TOM1L1 | target of myb1 (chicken)-like 1 | 0.096 | ||
| SH2B1 | SH2B adaptor protein 1 | 0.089 | ||
| DCAF7 | DDB1 and CUL4 associated factor 7 | 0.087 | ||
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.087 | Human | |
| STAT5B | signal transducer and activator of transcription 5B | 0.086 | ||
| ITGB1BP3 | integrin beta 1 binding protein 3 | 0.083 | ||
| PARD3 | par-3 partitioning defective 3 homolog (C. elegans) | 0.083 | ||
| PPP1CC | protein phosphatase 1, catalytic subunit, gamma isozyme | 0.082 | ||
| GSK3B | glycogen synthase kinase 3 beta | 0.076 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.072 | ||
| VEGFA | vascular endothelial growth factor A | 0.071 | Human | |
| DKK1 | dickkopf homolog 1 (Xenopus laevis) | 0.069 | ||
| SH3RF1 | SH3 domain containing ring finger 1 | 0.069 | ||
| RAB6A | RAB6A, member RAS oncogene family | 0.069 | ||
| DYRK2 | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 | 0.067 | ||
| EPOR | erythropoietin receptor | 0.066 | ||
| DYRK4 | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4 | 0.065 | Human | |
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.059 | ||
| AP2M1 | adaptor-related protein complex 2, mu 1 subunit | 0.055 | ||
| RB1 | retinoblastoma 1 | 0.055 | ||
| ENPP1 | ectonucleotide pyrophosphatase/phosphodiesterase 1 | 0.054 | ||
| PARD6A | par-6 partitioning defective 6 homolog alpha (C. elegans) | 0.053 | ||
| SEMA6A | sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A | 0.045 | ||
| PRKCA | protein kinase C, alpha | 0.043 | ||
| PPP1R9B | protein phosphatase 1, regulatory (inhibitor) subunit 9B | 0.043 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.042 | ||
| OCRL | oculocerebrorenal syndrome of Lowe | 0.035 | Human | |
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.034 | ||
| PARD6B | par-6 partitioning defective 6 homolog beta (C. elegans) | 0.033 | ||
| REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.033 | Human | |
| INPPL1 | inositol polyphosphate phosphatase-like 1 | 0.033 | ||
| MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | 0.032 | ||
| LCK | lymphocyte-specific protein tyrosine kinase | 0.032 | ||
| THBS1 | thrombospondin 1 | 0.031 | ||
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.031 | ||
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.031 | ||
| LRRK2 | leucine-rich repeat kinase 2 | 0.030 | ||
| PTPRZ1 | protein tyrosine phosphatase, receptor-type, Z polypeptide 1 | 0.029 | ||
| NCF1 | neutrophil cytosolic factor 1 | 0.027 | ||
| MAP3K1 | mitogen-activated protein kinase kinase kinase 1 | 0.027 | ||
| RPTOR | regulatory associated protein of MTOR, complex 1 | 0.027 | ||
| PRKCB | protein kinase C, beta | 0.026 | ||
| EPS15 | epidermal growth factor receptor pathway substrate 15 | 0.025 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.024 | ||
| PICK1 | protein interacting with PRKCA 1 | 0.023 | ||
| IGF2R | insulin-like growth factor 2 receptor | 0.023 | ||
| CAPRIN2 | caprin family member 2 | 0.023 | ||
| RICTOR | RPTOR independent companion of MTOR, complex 2 | 0.023 | ||
| PARD6G | par-6 partitioning defective 6 homolog gamma (C. elegans) | 0.022 | ||
| CCND3 | cyclin D3 | 0.021 | ||
| PDGFC | platelet derived growth factor C | 0.020 | ||
| CDCP1 | CUB domain containing protein 1 | 0.020 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.020 | Human | |
| APP | amyloid beta (A4) precursor protein | 0.019 | ||
| OSBP | oxysterol binding protein | 0.019 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.018 | ||
| SESN2 | sestrin 2 | 0.018 | ||
| MDM4 | Mdm4 p53 binding protein homolog (mouse) | 0.018 | ||
| STC1 | stanniocalcin 1 | 0.017 | ||
| CLTC | clathrin, heavy chain (Hc) | 0.016 | ||
| VHL | von Hippel-Lindau tumor suppressor | 0.016 | ||
| NMT2 | N-myristoyltransferase 2 | 0.016 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.016 | ||
| FOSL2 | FOS-like antigen 2 | 0.016 | ||
| ERBB4 | v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) | 0.016 | ||
| PRKACA | protein kinase, cAMP-dependent, catalytic, alpha | 0.015 | ||
| FAM117B | family with sequence similarity 117, member B | 0.015 | ||
| DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.015 | ||
| FSTL1 | follistatin-like 1 | 0.015 | ||
| EPM2A | epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) | 0.015 | ||
| DCN | decorin | 0.014 | ||
| ENPP5 | ectonucleotide pyrophosphatase/phosphodiesterase 5 (putative) | 0.014 | ||
| SH2D2A | SH2 domain containing 2A | 0.013 | ||
| DNAJB9 | DnaJ (Hsp40) homolog, subfamily B, member 9 | 0.013 | ||
| MAPT | microtubule-associated protein tau | 0.013 | ||
| CSK | c-src tyrosine kinase | 0.013 | ||
| GRB14 | growth factor receptor-bound protein 14 | 0.012 | ||
| ACVR2B | activin A receptor, type IIB | 0.012 | ||
| ARHGEF12 | Rho guanine nucleotide exchange factor (GEF) 12 | 0.012 | ||
| NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.012 | ||
| PID1 | phosphotyrosine interaction domain containing 1 | 0.012 | ||
| MAP1LC3A | microtubule-associated protein 1 light chain 3 alpha | 0.012 | ||
| ARRB2 | arrestin, beta 2 | 0.012 | ||
| APBB2 | amyloid beta (A4) precursor protein-binding, family B, member 2 | 0.012 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.011 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.011 | ||
| RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.011 | ||
| PIM1 | pim-1 oncogene | 0.011 | Yeast | |
| RAB14 | RAB14, member RAS oncogene family | 0.011 | ||
| LMTK2 | lemur tyrosine kinase 2 | 0.011 | ||
| GCKR | glucokinase (hexokinase 4) regulator | 0.011 | ||
| TNS4 | tensin 4 | 0.011 | ||
| PPP1R3F | protein phosphatase 1, regulatory (inhibitor) subunit 3F | 0.011 | ||
| BMX | BMX non-receptor tyrosine kinase | 0.010 | ||
| DIP2A | DIP2 disco-interacting protein 2 homolog A (Drosophila) | 0.010 | ||
| NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.010 | ||
| CUX1 | cut-like homeobox 1 | 0.010 | ||
| CCHCR1 | coiled-coil alpha-helical rod protein 1 | 0.010 |